Cost minimization analysis of subcutaneous and intravenous immunoglobulin treatment in Italy [0.03%]
意大利皮下和静脉注射免疫球蛋白治疗的成本最小化分析
Chiara Bini,Matteo Scortichini,Silvia Ripoli et al.
Chiara Bini et al.
Introduction: Human immunoglobulins are the standard of care for patients with immunodeficiencies and represent a first-line treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). This study aimed to eval...
Raúl Ortiz de Lejarazu,Esther Redondo Margüello,Ángel Gil de Miguel et al.
Raúl Ortiz de Lejarazu et al.
Introduction: Influenza vaccines are formulated each year to prevent serious illness in at-risk individuals, including elderly people. Healthcare decision-making is mainly based on the economic evaluations (EEs) (i.e., co...
Ridiscussioni nel processo decisionale dell’Agenzia Italiana del Farmaco: una valutazione quantitativa di cause e implicazioni [0.03%]
意大利药物管理局决策过程中的重新讨论：原因及影响的定量评估
Michele Caimmi,Beatrice Canali,Anita Ciarlo et al.
Michele Caimmi et al.
Introduction:: Until 2024, Pricing and Reimbursement (P&R) requests for medicinal products in Italy were assessed by two separate bodies within AIFA: at first by the Technical Scientific Committee (CTS), then by the Prici...
Italian Medicines Agency's reform and time until pricing and reimbursement decisions: a time-to-event analysis [0.03%]
意大利药品机构改革及至定价和报销决定的时间分析
Gian Marco Raspolini,Bruno Federico,Mario Cesare Nurchis et al.
Gian Marco Raspolini et al.
Introduction: The duration of pricing and reimbursement (P&R) negotiations is a key performance indicator for medicines agencies in universal health coverage systems. In early 2024, the Italian Medicines Agency (AIFA) und...
Come le Regioni possono utilizzare il Rapporto OsMed per condividere le azioni di miglioramento dell’appropriatezza [0.03%]
地区如何利用OsMed报告分享适宜性改进行动的经验教训
Silvia Sansone,Maria Cristina Carena,Giorgia Fedele et al.
Silvia Sansone et al.
Introduction:: Italy retains a unique wealth of information on drug usage, embodied in the OsMed Report, published since 2001 and based on data collected by the National Observatory on the Use of Medicines. The Report ana...
Non-profit research: an insight into the management and monitoring of clinical trials in Italy [0.03%]
意大利临床试验的管理和监管透视——非盈利性研究机构的视角
Fatima Tizi,Viviana Appolloni,Barbara Bonifacio et al.
Fatima Tizi et al.
Introduction: In January 2022, Italy fully implemented EU Regulation No. 536/2014, revolutionizing the national framework for clinical research on medicinal products. This marked a critical shift for non-profit sponsors, ...
The societal costs associated with patients with chronic spontaneous urticaria (CSU) in Italy [0.03%]
意大利慢性自发性荨麻疹（CSU）患者的社ysical和社会成本
Chiara Bini,Andrea Marcellusi,Virginia Scansetti et al.
Chiara Bini et al.
Introduction: Chronic spontaneous urticaria (CSU) is a debilitating dermatological disease. The study aimed to estimate the indirect costs and out-of-pocket expenses incurred by CSU patients in Italy. ...
Use of artificial intelligence to draft a mini-HTA report on a new medical device belonging to class IIb-III [0.03%]
人工智能辅助编写IIb-III类医疗设备的迷你HTA报告的通知
Andrea Messori,Sabrina Beltramini,Paola Crosasso et al.
Andrea Messori et al.
The rapid evolution of artificial intelligence (AI) in the pharmaceutical and medical device (MD) sectors has prompted interest in its potential role in supporting health technology assessment (HTA). This editorial presents an innovative pr...
Multicriterio e valutazioni economiche: verso una proposta per un nuovo framework per il prezzo dei farmaci in Italia [0.03%]
多准则与经济评估：意大利药品定价新框架的提案
Andrea Marcellusi,Aldo P Maggioni,Anna L Mandorino et al.
Andrea Marcellusi et al.
Introduction:: The drug pricing and reimbursement process in Italy lacks a structured and shared framework to translate therapeutic value into consistent economic criteria, especially in a regulatory context characterized...
Impatto clinico ed economico dell’emicrania in Italia: un’analisi di real-world evidence [0.03%]
意大利偏头痛的临床和经济影响：真实世界证据分析
Valentina Perrone,Simone Leonetti,Luca Degli Esposti et al.
Valentina Perrone et al.
Introduction:: This retrospective observational analysis evaluated the clinical, demographic, and economic burden of migraine patients in real-world Italian clinical practice. ...